HIV care continuum among men who have sex with men and persons who inject drugs in India: Barriers to successful engagement

Clinical Infectious Diseases

Volumn 61, Issue 11, 2015, Pages 1732-1741

  Mehta, Shruti H ^a   Lucas, Gregory M ^b   Solomon, Suniti ^c   Srikrishnan, Aylur K ^c   McFall, Allison M ^a   Dhingra, Neeraj ^d   Nandagopal, Paneerselvam ^c   Kumar, M Suresh ^c   Celentano, David D ^a   Solomon, Sunil S ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^d National AIDS Control Organisation   (India)

Author keywords

HIV care continuum; India; men who have sex with men; people who inject drugs.

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; DRUG ABUSE; DRUG USE; FEMALE; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PATIENT CARE; PERSONS WHO INJECT DRUGS; PREVALENCE; PRIORITY JOURNAL; SEXUALITY; VIRUS LOAD; CLINICAL TRIAL; COMPLICATION; HIGH RISK BEHAVIOR; HIV INFECTIONS; MALE HOMOSEXUALITY; NEEDLE SHARING; RISK FACTOR; SUBSTANCE ABUSE;

ADULT; CONTINUITY OF PATIENT CARE; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INDIA; MALE; NEEDLE SHARING; RISK FACTORS; RISK-TAKING; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84983094780     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ669     Document Type: Article

References (35)

1. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815-26.
2. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis 2014; 14:281-90.
3. Cohen MS, Chen YQ, McCauleyM, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
4. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural Kwa-Zulu-Natal, South Africa. Science 2013; 339:966-71.
5. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376:532-9.
6. UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Available at: http://www.unaids.org/sites/default/files/media- asset/90-90-90-en-0.pdf. Accessed 31 December 2014.
7. Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 2010; 14:731-47.
8. Alvarez-Uria G, Pakam R, Midde M, Naik PK. Entry, retention, and virological suppression in an HIV cohort study in India: description of the cascade of care and implications for reducing HIV-related mortality in low-and middle-income countries. Interdiscip Perspect Infect Dis 2013; doi:10. 1155/2013/384805.
9. Sarna A, Sebastian M, Bachani D, Sogarwal R, Battala M. Pretreatment loss-to-follow-up after HIV diagnosis from 27 counseling and testing centers across India: findings from a cohort study. J Int Assoc Provid AIDS Care 2014; 13:223-31.
10. Feelemyer J, Des Jarlais D, Arasteh K, Uuskula A. Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: an international systematic review. AIDS Behav 2015; 19:575-83.
11. Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement in care and viral suppression for HIVinfected injection drug users. AIDS 2013; 27:2559-66.
12. Millett GA, Peterson JL, Flores SA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet 2012; 380:341-8.
13. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-Report- 2013-en.pdf. Accessed 31 December 2014.
14. Gupte MD, Mehendale SM, Pandav CS, Paranjape RS, Kumar MS. HIV-1 prevalence in young adults in south India. Lancet 2006; 368: 114-6.
15. National AIDS Control Organisation. Annual report. Available at: http://www.naco.gov.in/NACO/Quick-Links/Publication/Annual- Report/NACO-Annual-Report/Annual-Report-NACO-2014-15- English/. Accessed 18 August 2015.
16. National AIDS Control Organisation. Details of ICTC centres. Available at: http://www.naco.gov.in/NACO/Directory-of-Services/Details-of- ICTC-Centres-/. Accessed 31 December 2014.
17. National AIDS Control Organisation. List of ART centres in India. Available at: http://www.naco.gov.in/upload/2014%20mslns/CST/List %20of%20ART%20Centres%20in%20India.pdf. Accessed 18 August 2015.
18. Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl 2002; 49:11-34.
19. Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997; 44:174-99.
20. Solomon SS, Lucas GM, Celentano DD, Sifakis F, Mehta SH. Beyond surveillance: a role for respondent-driven sampling in implementation science. Am J Epidemiol 2013; 178:260-7.
21. Solomon SS, Mehta SH, Srikrishanan AK, et al. High HIV prevalence and incidence among men who have sex with men (MSM) across 12 cities in India. AIDS 2015; 29:723-31.
22. Lucas G, Solomon SS, Srikrishanan A, et al. High HIV burden among people who inject drugs in 15 Indian cities. AIDS 2015; 29:619-28.
23. MacArthur GJ, Minozzi S, Martin N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012; 345:e5945.
24. Gowing L, FarrellMF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2011; doi:10. 1002/14651858. CD004145. pub4.
25. National AIDS Control Organisation. Guidelines on HIV testing. Available at: http://naco.gov.in/upload/Policies & Guidelines/5-GUILDELINES FOR HIV TESTING.pdf. Accessed 31 December 2014.
26. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat 2008; 24:79-97.
27. Office of the Registrar General & Census Commissioner of India 2011 Census district profiles Available at http://censusindia.gov.in/Tables- Published/Basic-Data-Sheet. aspx. Accessed 8 May 2014.
28. National Institute of Medical Statistics and National Aids Control Organisation. Technical report: India HIV estimates. 2010. Available at: http://naco.gov.in/upload/Surveillance/Reports & Publication/Technical Report India HIV Estimates 2010.pdf. Accessed 31 December 2014.
29. Salganik M, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Soc Probl 2004; 49:11-34.
30. Arora P, Kumar R, Bhattacharya M, Nagelkerke NJ, Jha P. Trends in HIV incidence in India from 2000 to 2007. Lancet 2008; 372:289-90.
31. Hingankar NK, Thorat SR, Deshpande A, et al. Initial virologic response and HIV drug resistance among HIV-Infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. Clin Infect Dis 2012; 54(suppl 4):S348-54.
32. Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One 2011; 6:e19201.
33. Clouse K, Pettifor AE, Maskew M, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2013; 62:e39-46.
34. Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis 2013; 57:1309-17.
35. Solomon SS, Srikrishnan AK, Vasudevan CK, et al. Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India. Clin Infect Dis 2014; 59:589-95.